Report Overview

The Global Obesity drugs market size stood at USD 7.1 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Obesity poses an enormous challenge for the developed countries and the lower and middle-income economies. As per the World Health Organization fact file, overweight and obesity are associated with various diseases and contribute to a higher mortality rate as compared to malnourishment. The overweight and obese population report a high prevalence of chronic diseases including hypertension, diabetes, and orthopaedic diseases.



Market Drivers

The shifting preference toward sedentary lifestyles, physical inactivity, and changing food habits leads to weight gain in adolescents. The increase in one-person households, nuclear families, and families with working parents are engendering the adoption of unhealthy lifestyles, which is propelling the demand for accessible and inexpensive fast-food meals.

The increasingly busy schedules and the growing stress are causing people to consume ready-to-eat food. Also, the food consumption tendencies amongst the young lean toward overeating and low nutrient intake, which is leading to untoward health effects. The increasing number of obese adolescents and overweight individuals over 18 years of age is rising due to physical inactivity, incessant playing of video games, and long hours of television viewing.